Dr.Reddy's Laboratories Ltd (REDY.BO)
* Says audit of our API Cuernavaca plant at Mexico, by US FDA, has been completed with zero observations Source text for Eikon: Further company coverage:
* Says formulations Srikakulam Plant (SEZ) unit I, Andhra Pradesh, by US FDA, has been completed Friday
* Dr.Reddy's Laboratories clarifies on news item, "Dr Reddy's recalls 3.25l cartons Cipla-made acne drug from US".
* Says got EIR after audit of API manufacturing plant at Miryalaguda, by US FDA, as closure of audit Source text - (http://bit.ly/2smE0VK) Further company coverage:
* Says announces launch of Bivalirudin for injection in U.S. market Source text for Eikon: Further company coverage:
BRIEF-Dr.Reddy's Labs' audit of formulations Srikakulum plant Unit II completed with zero observations
* Says audit of formulations Srikakulum Plant unit II, Andhra Pradesh by US FDA, completed with zero observations. Source text - (http://bit.ly/2qnkt2M) Further company coverage:
BRIEF-Dr.Reddy's Laboratories says USFDA approved launch of doxorubicin hydrochloride liposome injection in U.S.
* Announces USFDA approval for launch of doxorubicin hydrochloride liposome injection in U.S. Market Source text - (http://bit.ly/2qQ6RC6) Further company coverage:
* Consensus forecast for March quarter consol profit was 4.27 billion rupees
* Says launch of Ezetimibe and Simvastatin tablets in U.S. market Source text for Eikon: Further company coverage:
* Fresenius ceo sturm says we've had a good q1 but will not provide details